Copyright © 2000 by the European Society of Cardiology.
Epidemiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy
a Laboratoire de Génétique et Insuffisance Cardiaque, Association Claude Bernard/Université Paris VI, Groupe hospitalier Pitié-Salpêtrière, Paris, France
b IFR 14 Coeur, Muscles et Vaisseaux, Paris, France
c Istituto di Anatomia Patologica e Diagnostica Molecolare, IRCCS Policlinico San Matteo, Pavia, Italy
d Service de Cardiologie, Groupe hospitalier Pitié-Salpêtrière, Paris, France
e Cardiology Department, IRCCS Policlinico San Matteo, Pavia, Italy
Received April 18, 2000; accepted April 19, 2000
Abstract
Aims Although dilated cardiomyopathy is the most frequent form of cardiomyopathy, its aetiology is still poorly understood. In about 2030% of cases the disease is familial with a large predominance of autosomal dominant transmission. Ten different chromosomal loci have been described for autosomal dominant forms of dilated cardiomyopathy. Only two genes have been associated with pure forms (without myopathy and/or conduction disorders) of the disease, the cardiac actin and the desmin genes. Our aim was to determine the proportion of dilated cardiomyopathy affected individuals carrying a mutation in one of these two genes.
Methods and Results We performed (1) a systematic polymerase chain reaction-SSCP-sequencing screening of the coding sequences of cardiac actin on DNA samples from 43 probands of dilated cardiomyopathy families and 43 sporadic cases; (2) a systematic polymerase chain reaction-SSCP-sequencing screening of the coding sequences of desmin combined with a search for the described missense mutation (Ile451Met) by restriction fragment length polymorphism analysis on DNA samples from 41 probands of dilated cardiomyopathy families and 22 sporadic cases.
Conclusion None of the patients presents a mutation in any of these two genes. Consequently, the proportion of European dilated cardiomyopathy affected individuals bearing a mutation in (1) the cardiac actin gene is less than 1·2%, (2) the desmin gene is less than 1·6%.
Key Words: Familial dilated cardiomyopathy, cardiac actin gene, desmin gene
f1 Correspondence: Professor Michel Komajda, Service de Cardiologie, Groupe hospitalier Pitié-Salpêtrière 47 bd de l'Hôpital, 75651 Paris cedex 13, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Duboscq-Bidot, P. Xu, P. Charron, N. Neyroud, G. Dilanian, A. Millaire, V. Bors, M. Komajda, and E. Villard Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy Cardiovasc Res, January 1, 2008; 77(1): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R.G. Taylor, D. Slavov, L. Ku, A. Di Lenarda, G. Sinagra, E. Carniel, K. Haubold, M. M. Boucek, D. Ferguson, S. L. Graw, et al. Prevalence of Desmin Mutations in Dilated Cardiomyopathy Circulation, March 13, 2007; 115(10): 1244 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Arbustini, M. Pasotti, A. Pilotto, C. Pellegrini, M. Grasso, S. Previtali, A. Repetto, O. Bellini, G. Azan, M. Scaffino, et al. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects Eur J Heart Fail, August 1, 2006; 8(5): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Sylvius, Z T Bilinska, J P Veinot, A Fidzianska, P M Bolongo, S Poon, P McKeown, R A Davies, K-L Chan, A S L Tang, et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients J. Med. Genet., August 1, 2005; 42(8): 639 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Burkett and R. E. Hershberger Clinical and genetic issues in familial dilated cardiomyopathy J. Am. Coll. Cardiol., April 5, 2005; 45(7): 969 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Villard, L. Duboscq-Bidot, P. Charron, A. Benaiche, V. Conraads, N. Sylvius, and M. Komajda Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene Eur. Heart J., April 2, 2005; 26(8): 794 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Osterziel and A. Perrot Dilated cardiomyopathy: more genes means more phenotypes Eur. Heart J., April 2, 2005; 26(8): 751 - 754. [Full Text] [PDF] |
||||
![]() |
E. Arbustini, A. Repetto, M. Pasotti, G. Azan, C. Opasich, C. Campana, A. Gavazzi, R. Ferrari, and L. Tavazzi Cardiomyology: an attempt to link structural cardiac and skeletal muscle damage in patients with dilated cardiomyopathy Eur. Heart J. Suppl., November 1, 2004; 6(suppl_F): F40 - F53. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Di Somma, M.P. Di Benedetto, G. Salvatore, L. Agozzino, F. Ferranti, S. Esposito, P. La Dogana, M.I. Scarano, G. Caputo, M. Cotrufo, et al. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure Eur J Heart Fail, June 1, 2004; 6(4): 389 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Not, E. Faleschini, A. Tommasini, A. Repetto, M. Pasotti, V. Baldas, A. Spano, D. Sblattero, R. Marzari, C. Campana, et al. Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives Eur. Heart J., August 1, 2003; 24(15): 1455 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Sebillon, C Bouchier, L D Bidot, G Bonne, K Ahamed, P Charron, V Drouin-Garraud, A Millaire, G Desrumeaux, A Benaiche, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations J. Med. Genet., August 1, 2003; 40(8): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Doevendans Genetic Polymorphisms and Cardiac Failure Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 23 - 29. [PDF] |
||||
![]() |
D. Fatkin and R. M. Graham Molecular Mechanisms of Inherited Cardiomyopathies Physiol Rev, October 1, 2002; 82(4): 945 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Mahon, B. P. Madden, A. L. P. Caforio, P. M. Elliott, A. J. Haven, B. E. Keogh, M. J. Davies, and W. J. McKenna Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy J. Am. Coll. Cardiol., February 6, 2002; 39(3): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyamoto, H. Akita, N. Shiga, E. Takai, C. Iwai, K. Mizutani, H. Kawai, A. Takarada, and M. Yokoyama Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population Eur. Heart J., December 2, 2001; 22(24): 2284 - 2289. [Abstract] [PDF] |
||||
![]() |
C.A. MacRae Genetics and dilated cardiomyopathy: limitations of candidate gene strategies Eur. Heart J., November 2, 2000; 21(22): 1817 - 1819. [PDF] |
||||








